Skip to content

Evaluation of the effect of Ultranamel spray on dental plaque and gingival inflammation

Evaluation of the effect of Ultranamel spray on dental plaque and gingival inflammation

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240216061025N1
Enrollment
30
Registered
2025-07-26
Start date
2025-09-23
Completion date
Unknown
Last updated
2025-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gingivitis. Acute gingivitis, plaque induced

Interventions

Intervention 1: Control group: First, polishing will be performed on all samples to minimize plaque. During this period, the subjects will use the same toothbrush and toothpaste as instructed for two

Sponsors

Qazvin University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Being dentate (at least 22 natural teeth) and having all of the teeth in sextant 2 Complete periodontal health

Exclusion criteria

Exclusion criteria: Wearing of orthodontic appliances Wearing of any form of intraoral removable prostheses Suffering from any systemic disease affecting gingivitis (diabetes, blood pressure, etc.) The presence of any medical or pharmaceutical measures (such as taking antibiotics, anti-inflammatory or contraceptive drugs) that could affect the study during the last 3 months Using mouthwash, gel or gum containing antimicrobial agents in the last 3 months Pregnancy or breastfeeding

Design outcomes

Primary

MeasureTime frame
Dental plaque. Timepoint: Measurement of dental plaque levels is performed immediately after the completion of each intervention period, i.e. two weeks after the start of the intervention period. Method of measurement: Turesky modification of quigley-hein plaque index.

Secondary

MeasureTime frame
Gingivitis. Timepoint: Measurement of dental plaque levels is performed immediately after the completion of each intervention period, i.e. two weeks after the start of the intervention period. Method of measurement: Gingival index(Sillness and Loe).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSepehr Javaheri

Qazvin University of Medical Sciences

sepehrjvhr@gmail.com+98 28 3335 3061

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026